José Antonio Ros Lucas-rekin lankidetzan egindako argitalpenak (2)

2023

  1. Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19

    Medicina Clinica, Vol. 161, Núm. 5, pp. 185-191

2022

  1. CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia

    Scientific Reports, Vol. 12, Núm. 1